227 related articles for article (PubMed ID: 33225311)
21. Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation.
Viganò E; Gunawardana J; Mottok A; Van Tol T; Mak K; Chan FC; Chong L; Chavez E; Woolcock B; Takata K; Twa D; Shulha HP; Telenius A; Kutovaya O; Hung SS; Healy S; Ben-Neriah S; Leroy K; Gaulard P; Diepstra A; Kridel R; Savage KJ; Rimsza L; Gascoyne R; Steidl C
Blood; 2018 May; 131(18):2036-2046. PubMed ID: 29467182
[TBL] [Abstract][Full Text] [Related]
22. Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndrome.
Kiel MJ; Sahasrabuddhe AA; Rolland DCM; Velusamy T; Chung F; Schaller M; Bailey NG; Betz BL; Miranda RN; Porcu P; Byrd JC; Medeiros LJ; Kunkel SL; Bahler DW; Lim MS; Elenitoba-Johnson KSJ
Nat Commun; 2015 Sep; 6():8470. PubMed ID: 26415585
[TBL] [Abstract][Full Text] [Related]
23. Plasmablastic lymphoma in HIV patients: Experience at a tertiary care hospital in eastern India.
Bishnu S; Banerjee S; Bandyopadhyay D; Samui S; Bhattacharya S; Bose D
Indian J Cancer; 2015; 52(4):563-7. PubMed ID: 26960478
[TBL] [Abstract][Full Text] [Related]
24. Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area.
Meer S; Perner Y; McAlpine ED; Willem P
Histopathology; 2020 Jan; 76(2):212-221. PubMed ID: 31361906
[TBL] [Abstract][Full Text] [Related]
25. Plasmablastic lymphoma: current knowledge and future directions.
Li JW; Peng HL; Zhou XY; Wang JJ
Front Immunol; 2024; 15():1354604. PubMed ID: 38415257
[TBL] [Abstract][Full Text] [Related]
26. Plasmablastic lymphoma in Johannesburg, South Africa, in the era of widescale antiretroviral therapy use.
Vaughan J; Perner Y; Mayne E; Wiggill T
HIV Med; 2021 Mar; 22(3):225-230. PubMed ID: 33022825
[TBL] [Abstract][Full Text] [Related]
27. Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for Immunotherapy.
Waldmann TA; Chen J
Annu Rev Immunol; 2017 Apr; 35():533-550. PubMed ID: 28182501
[TBL] [Abstract][Full Text] [Related]
28. Plasmablastic lymphoma of the oral cavity, a B cell-derived lymphoma associated with HIV infection: a case series.
Tsachouridou O; Christoforidou A; Metallidis S; Papaioannou M; Kollaras P; Kolokotronis A; Chrysanthidis T; Pilalas D; Markou K
Eur Arch Otorhinolaryngol; 2012 Jun; 269(6):1713-9. PubMed ID: 22350427
[TBL] [Abstract][Full Text] [Related]
29. Lymphoid neoplasms of the oral cavity with plasmablastic morphology-a case series and review of the literature.
Bhattacharyya S; Bains APS; Sykes DL; Iverson BR; Sibgatullah R; Kuklani RM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Dec; 128(6):651-659. PubMed ID: 31494113
[TBL] [Abstract][Full Text] [Related]
30. Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph).
Butterbach K; Beckmann L; de Sanjosé S; Benavente Y; Becker N; Foretova L; Maynadie M; Cocco P; Staines A; Boffetta P; Brennan P; Nieters A
Br J Haematol; 2011 May; 153(3):318-33. PubMed ID: 21418178
[TBL] [Abstract][Full Text] [Related]
31. TC-PTP and PTP1B: Regulating JAK-STAT signaling, controlling lymphoid malignancies.
Pike KA; Tremblay ML
Cytokine; 2016 Jun; 82():52-7. PubMed ID: 26817397
[TBL] [Abstract][Full Text] [Related]
32. Plasmablastic lymphoma presenting as a large intracardiac mass and bilateral pleural effusions.
Qing X; Enbom E; Qing A; French S; Cai J
Exp Mol Pathol; 2016 Feb; 100(1):79-81. PubMed ID: 26607603
[TBL] [Abstract][Full Text] [Related]
33. [Plasmablastic lymphoma].
Fernández-Álvarez R; Sancho JM; Ribera JM
Med Clin (Barc); 2016 Nov; 147(9):399-404. PubMed ID: 27576534
[TBL] [Abstract][Full Text] [Related]
34. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
[TBL] [Abstract][Full Text] [Related]
35. Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.
Lee S; Park HY; Kang SY; Kim SJ; Hwang J; Lee S; Kwak SH; Park KS; Yoo HY; Kim WS; Kim JI; Ko YH
Oncotarget; 2015 Jul; 6(19):17764-76. PubMed ID: 25980440
[TBL] [Abstract][Full Text] [Related]
36. The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.
Di Ciaccio PR; Polizzotto MN; Cwynarski K; Gerrie AS; Burton C; Bower M; Kuruvilla J; Montoto S; McKay P; Fox CP; Milliken S; Jiamsakul A; Osborne W; Collins GP; Manos K; Linton KM; Iyengar S; Kassam S; Limei MP; Kliman D; Wong Doo N; Watson AM; Fedele P; Yannakou CK; Hunt S; Ku M; Sehn LH; Smith A; Renshaw H; Maxwell A; Liu Q; Dhairyawan R; Ferguson G; Pickard K; Painter D; Thakrar N; Song KW; Hamad N
Blood; 2024 Jan; 143(2):152-165. PubMed ID: 37832030
[TBL] [Abstract][Full Text] [Related]
37. High incidence of MYC rearrangement in human immunodeficiency virus-positive plasmablastic lymphoma.
Miao L; Guo N; Feng Y; Rao H; Wang F; Huang Q; Huang Y
Histopathology; 2020 Jan; 76(2):201-211. PubMed ID: 31348551
[TBL] [Abstract][Full Text] [Related]
38. Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
Dufva O; Kankainen M; Kelkka T; Sekiguchi N; Awad SA; Eldfors S; Yadav B; Kuusanmäki H; Malani D; Andersson EI; Pietarinen P; Saikko L; Kovanen PE; Ojala T; Lee DA; Loughran TP; Nakazawa H; Suzumiya J; Suzuki R; Ko YH; Kim WS; Chuang SS; Aittokallio T; Chan WC; Ohshima K; Ishida F; Mustjoki S
Nat Commun; 2018 Apr; 9(1):1567. PubMed ID: 29674644
[TBL] [Abstract][Full Text] [Related]
39. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
Chen J; Zhang Y; Petrus MN; Xiao W; Nicolae A; Raffeld M; Pittaluga S; Bamford RN; Nakagawa M; Ouyang ST; Epstein AL; Kadin ME; Del Mistro A; Woessner R; Jaffe ES; Waldmann TA
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3975-3980. PubMed ID: 28356514
[TBL] [Abstract][Full Text] [Related]
40. Human immunodeficiency virus-negative plasmablastic lymphoma in Korea.
Kim JE; Kim YA; Kim WY; Kim CW; Ko YH; Lee GK; Choi SJ; Jeon YK
Leuk Lymphoma; 2009 Apr; 50(4):582-7. PubMed ID: 19373656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
